ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)

Clinical trial NCT01445600 · COMPLETED

Trial details

NCT number: NCT01445600
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Skin Infections, Bacterial

Start date: 2012-11-01
Primary completion: 2015-08-01
Enrollment: 3612

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.